Cargando…

Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial

AIM: The aim of this clinical trial is to compare the clinical and radiographic success of Aloe vera and formocresol (FC) as a pulpotomy medicament in primary molars. MATERIALS AND METHODS: A total of 72 asymptomatic or symptomatic vital primary molars were selected and were assigned to two groups:...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramanyam, Divya, Somasundaram, Sujatha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366759/
https://www.ncbi.nlm.nih.gov/pubmed/32742090
http://dx.doi.org/10.5005/jp-journals-10005-1724
_version_ 1783560287452921856
author Subramanyam, Divya
Somasundaram, Sujatha
author_facet Subramanyam, Divya
Somasundaram, Sujatha
author_sort Subramanyam, Divya
collection PubMed
description AIM: The aim of this clinical trial is to compare the clinical and radiographic success of Aloe vera and formocresol (FC) as a pulpotomy medicament in primary molars. MATERIALS AND METHODS: A total of 72 asymptomatic or symptomatic vital primary molars were selected and were assigned to two groups: group II: Buckley's FC, group II: Aloe vera gel. The clinical and radiographic success were evaluated using Zurn and Seale criteria. The data were statistically analyzed using the Chi-square test. RESULTS: At three and 6 months follow-up, the clinical success rate of Aloe vera and FC was equally effective. Aloe vera showed a higher radiographic success rate compared to FC (p > 0.05). At 6 months follow-up, FC showed a higher radiographic success rate compared to Aloe vera (p > 0.05). CONCLUSION: The clinical and radiographic success of both groups were equally effective at the end of 6 months follow-up. Aloe vera can be considered as an alternative pulpotomy medicament to FC. But, further long-term follow-up studies and histological studies are required. HOW TO CITE THIS ARTICLE: Subramanyam D, Somasundaram S. Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial. Int J Clin Pediatr Dent 2020;13(2):138–143.
format Online
Article
Text
id pubmed-7366759
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-73667592020-07-31 Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial Subramanyam, Divya Somasundaram, Sujatha Int J Clin Pediatr Dent Original Article AIM: The aim of this clinical trial is to compare the clinical and radiographic success of Aloe vera and formocresol (FC) as a pulpotomy medicament in primary molars. MATERIALS AND METHODS: A total of 72 asymptomatic or symptomatic vital primary molars were selected and were assigned to two groups: group II: Buckley's FC, group II: Aloe vera gel. The clinical and radiographic success were evaluated using Zurn and Seale criteria. The data were statistically analyzed using the Chi-square test. RESULTS: At three and 6 months follow-up, the clinical success rate of Aloe vera and FC was equally effective. Aloe vera showed a higher radiographic success rate compared to FC (p > 0.05). At 6 months follow-up, FC showed a higher radiographic success rate compared to Aloe vera (p > 0.05). CONCLUSION: The clinical and radiographic success of both groups were equally effective at the end of 6 months follow-up. Aloe vera can be considered as an alternative pulpotomy medicament to FC. But, further long-term follow-up studies and histological studies are required. HOW TO CITE THIS ARTICLE: Subramanyam D, Somasundaram S. Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial. Int J Clin Pediatr Dent 2020;13(2):138–143. Jaypee Brothers Medical Publishers 2020 /pmc/articles/PMC7366759/ /pubmed/32742090 http://dx.doi.org/10.5005/jp-journals-10005-1724 Text en Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd. © The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Subramanyam, Divya
Somasundaram, Sujatha
Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial
title Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial
title_full Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial
title_fullStr Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial
title_full_unstemmed Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial
title_short Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial
title_sort clinical and radiographic evaluation of aloe vera vs formocresol as a pulpotomy medicament in primary molars: a double blinded randomized controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366759/
https://www.ncbi.nlm.nih.gov/pubmed/32742090
http://dx.doi.org/10.5005/jp-journals-10005-1724
work_keys_str_mv AT subramanyamdivya clinicalandradiographicevaluationofaloeveravsformocresolasapulpotomymedicamentinprimarymolarsadoubleblindedrandomizedcontrolledtrial
AT somasundaramsujatha clinicalandradiographicevaluationofaloeveravsformocresolasapulpotomymedicamentinprimarymolarsadoubleblindedrandomizedcontrolledtrial